What VRPharma does

VRPharma (legal entity: VRPHARMA INMERSIVE TECHNOLOGIES S.L.) is a Spain-based healthcare technology company that has developed a clinically validated virtual reality platform designed to reduce pain, anxiety, and fear experienced by patients during medical procedures. The platform combines VR goggles with a proprietary content library (modules named Young Heroes, Look Up!, Happy Thoughts, and Relax) and a tablet-based real-time control interface that allows clinical staff to monitor and synchronize the immersive experience with procedures. The company was founded in 2021 by Mireia Cigarrán, motivated by personal experiences of healthcare trauma with her children and parents, and is headquartered in San Sebastián (Donostia), Spain, with the firmographic listing also referencing Sant Cugat Del Vallès.

The platform is deployed across pediatric, adult, ICU, oncology, palliative care, and dialysis units in Spanish hospitals and primary care centers, with peer-reviewed clinical evidence published in Scientific Reports demonstrating 25% pain reduction and 30% anxiety reduction during cardiac ICU chest tube removal procedures, plus an 80% no-pain rate reported for children using the Young Heroes module during needle procedures. The go-to-market is direct enterprise sales to healthcare facilities using a consultation-based selling model with custom enterprise pricing and multi-year contracts; a secondary sales motion targets beauty, spa, and wellness facilities.

VRPharma's business model rests on hardware sales (VR goggles) bundled with proprietary software content, generating revenue through per-deployment enterprise contracts. Distribution is currently concentrated entirely within Spain, with named reference customers including Vall d'Hebron Barcelona Hospital Campus, Hospital Universitario de Bellvitge, Hospital Cruces Osakidetza, Germans Trias i Pujol Hospital, Consorci Sanitari de Terrassa, and CAP de Súria. The company's only disclosed external funding is a €30,000 in-kind subsidy from the PADIH program via ITCL Centro Tecnológico in 2024, with no institutional venture or private equity investment evidenced in the available data.

Name

VRPharma

Legal name

VRPHARMA INMERSIVE TECHNOLOGIES S.L.

Website

https://vrpharma.io

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

VRPharma is a Spain-based virtual reality healthcare platform that delivers clinically validated VR content to reduce pain, anxiety, and stress in pediatric and adult patients during medical procedures, selling hardware-plus-software bundles to hospitals and clinics via direct enterprise sales.

Ownership category

akta.pro rank

Product category

Clinical Virtual Reality Healthcare Platform

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction) (EDAFAJAC)

akta.pro secondary industry

VR/AR Gaming Hardware (Headsets & Controllers) (HDACANAD)

Keywords

• Virtual reality healthcare
• Pediatric pain management
• Clinical VR platform
• Non-pharmacological analgesia
• Hospital patient experience

Headquarters

HQ city

Sant Cugat Del Vallès

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

1. VR Hardware and Software Platform: VRPharma provides virtual reality hardware (VR goggles) along with proprietary VR content/software for healthcare facilities. The platform is sold to medical centers as a complete solution for improving patient experience during medical procedures.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

VRPharma provides a clinically validated virtual reality platform combining VR goggles, proprietary content modules, and tablet-based control software for healthcare facilities. The platform is sold to hospitals and medical centers to reduce pain, anxiety, and fear during medical procedures across pediatrics, adult care, oncology, ICU, palliative care, and dialysis units. Four content experiences (Young Heroes, Look Up!, Happy Thoughts, Relax) are tailored to specific clinical scenarios and patient populations.

Product overview

VRPharma offers a clinically validated virtual reality platform for healthcare settings, combining VR hardware (goggles) with a content library and tablet-based control system. The platform includes four named VR experience modules: Young Heroes (for needle procedures in pediatrics), Look Up! (for procedures requiring stillness), Happy Thoughts (for emotional well-being), and Relax (for hospital stays and transfers). The platform is deployed across pediatrics, adult, oncology, intensive care, palliative care, and dialysis units to reduce pain, anxiety, and stress during medical procedures. Published clinical trials demonstrate outcomes including 80% of children reporting no pain during injections and 99.4% of patients recommending the solution.

Differentiator

Problem solved

Functional benefit

Products and services

• VRPharma Platform A clinically validated virtual reality platform delivering immersive experiences through VR goggles controlled via tablet, designed to reduce pain, anxiety, and stress during medical procedures across pediatrics, adult, ICU, oncology, palliative care, and dialysis settings. Sold to healthcare facilities as a complete solution including hardware, proprietary content, and staff training/support.
• Young Heroes Pediatric VR experience featuring the avatar Leia who guides children through needle procedures (vaccinations, blood tests, IV placements) with empowerment and calm, transforming the perception of injections; 80% of children report no pain or only minor discomfort.
• Look Up! VR experience bringing smiles during care and treatments requiring patients to lie still, including emergency visits, dental procedures, and routine care.
• Happy Thoughts VR content providing emotional well-being by fostering connection with the real world, nature, and cultivating a sense of abundance during medical treatments.
• Relax VR experience offering relaxation and distraction therapies during hospital stays, operating room transfers, diagnostic tests, and other medical procedures requiring patient calm.

Quantifiable outcome

• 99.3% of patients would recommend VRPharma
• +6 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• ITCL Centro TecnológicominorStrategic or Co-development Partner · 1 January 2024VRPharma is beneficiary of PADIH program for contracting IT services from ITCL Centro Tecnológico. Received in-kind subsidy of €30,000 under Expte. 2024/DIH_01/000421.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• BehaVR: BehaVR builds VR experiences for mental health, chronic pain, and behavioral therapy sold to providers and payers. Its content-module approach to multi-condition coverage (anxiety, chronic pain, behavioral) overlaps directly with VRPharma's content library strategy (Young Heroes, Look Up!, Relax, Happy Thoughts).
• AppliedVR: AppliedVR develops FDA-authorized VR therapeutics for chronic pain and procedural anxiety, directly mirroring VRPharma's distraction-therapy positioning. Both sell to hospitals/provider systems on a multi-year enterprise basis with clinically validated outcomes as the primary selling proposition.
• Oncomfort: Oncomfort provides VR-based digital sedation and anxiety management for medical procedures across European hospitals. It is one of the closest head-to-head competitors to VRPharma's procedural sedation and pediatric use cases, particularly in EU hospital procurement channels.
• XRHealth: XRHealth offers a VR platform for pain management, anxiety, and neurological rehabilitation delivered through clinics and remote therapists. It is directly comparable to VRPharma in product modality (clinically validated VR therapy), target buyer (healthcare providers), and business model (enterprise + clinician-prescribed use).

Emerging players

• SyncThink: SyncThink uses VR/eye-tracking for neurological assessment and recovery, initially in sports concussion and now expanding to broader clinical use. It is comparable to VRPharma as a clinical-VR vendor with hospital sales, though more focused on assessment than procedural distraction.
• Psious: Psious provides VR environments for mental-health clinicians treating anxiety, phobias, and stress. Comparable to VRPharma in the mental-health/relaxation content modules (Happy Thoughts, Relax) and clinician-facing positioning.
• FundamentalVR: FundamentalVR provides VR/haptic simulation for surgical training and clinical education. It is comparable to VRPharma in healthcare-VR domain specialization and clinical validation requirements, although its primary use case is clinician training rather than patient-side distraction therapy.
• Virtual Reality Medical Center (VRMC): VRMC delivers VR-based exposure therapy for phobias, anxiety, and PTSD in clinical settings. Overlaps with VRPharma's mental-health-for-staff pilot at Germans Trias i Pujol and broader anxiety reduction use cases in adult hospital populations.

Broad incumbents

• Surgical Science / Simbionix: Surgical Science (Simbionix) is an established medical simulation vendor selling VR-based training platforms to hospitals. Comparable as a broader incumbent with VR-in-healthcare infrastructure, though oriented to procedural training rather than patient emotional support.
• Siemens Healthineers (VR/simulation portfolio): Siemens Healthineers is a broad medical-technology incumbent with adjacent clinical simulation and digital health offerings. Comparable as a strategic threat and potential acquirer in clinical VR adoption, though its VR offerings are typically part of a much wider portfolio rather than specialized.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/vr_pharma
• Facebookfacebook.com/VRPharma.health
• LinkedInlinkedin.com/company/vrpharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VRPharma